SyntekaBio, Inc. (KOSDAQ:226330)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,390.00
+20.00 (0.46%)
At close: Sep 18, 2025

SyntekaBio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-17,983-7,213-11,398-4,506-14,803-6,488
Depreciation & Amortization
2,1742,2541,7621,4731,1581,058
Loss (Gain) From Sale of Assets
-5.73--0.13--0.15
Asset Writedown & Restructuring Costs
23.261.267220.25--
Stock-Based Compensation
472.88572.84779.78793.17364.78568.15
Provision & Write-off of Bad Debts
-----0.27-0.52
Other Operating Activities
4,801-5,977778.98-5,8136,984-20.39
Change in Accounts Receivable
-184.360.060.8353.97-32.156.19
Change in Unearned Revenue
----171.11--
Change in Other Net Operating Assets
-1,025-152.95-73.97-360.5288.52208.86
Operating Cash Flow
-11,721-10,509-8,078-8,511-6,040-4,668
Capital Expenditures
-61.67-5,707-9,364-8,389-7,479-788.88
Sale of Property, Plant & Equipment
---0.13-0.15
Sale (Purchase) of Intangibles
-97.49-109.79-65.61-368.06-69.14-97.51
Investment in Securities
---39,000-560-10,440
Other Investing Activities
8.9520-0-9.964.52-60
Investing Cash Flow
-150.21-5,797-9,43030,233-8,104-11,386
Long-Term Debt Issued
-10,00010,000-25,000-
Long-Term Debt Repaid
--1,730-8,228-263.16-402-430.8
Net Debt Issued (Repaid)
2,1908,2701,772-263.1624,598-430.8
Issuance of Common Stock
-26212174.13414.151,657
Other Financing Activities
-0-0-0-196.51261.31
Financing Cash Flow
2,1908,5321,784-89.0325,2091,488
Foreign Exchange Rate Adjustments
99.55171.548.83-0.08-6.44-
Miscellaneous Cash Flow Adjustments
-0----0
Net Cash Flow
-9,581-7,602-15,67421,63411,058-14,567
Free Cash Flow
-11,782-16,216-17,442-16,899-13,520-5,457
Free Cash Flow Margin
-886.89%-13413.89%-14133.89%-6926.24%-4269.46%-895.05%
Free Cash Flow Per Share
-772.18-908.21-1218.35-1250.52-1004.13-411.97
Cash Income Tax Paid
--130.5642.7967.64-8.7140.21
Levered Free Cash Flow
-14,596-19,769-9,212-1,735-15,780-
Unlevered Free Cash Flow
-12,858-18,514-8,977-952.52-15,621-
Change in Working Capital
-1,209-152.9-73.15-477.65256.37215.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.